Replies to post #2888 on Intellipharmaceutics International Inc. (IPCI)

[YankeMike]

They raised their price target BECAUSE of the FDA approval. The stock would probably have gone up just as much without the price target having been raised. Fundamentals are now causing a new price level to be set. This thing is marching to $15 by the end of next year with more FDA approvals expected.